Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Crazy Fools Chasing Crazy CyberNews -- Ignore unavailable to you. Want to Upgrade?

To: ms.smartest.person who wrote (4106)	4/18/2003 4:54:06 PM
From: ms.smartest.person	Read Replies (1) \| Respond to of 5140

Synbiotics Corporation is a provider of rapid diagnostic and laboratory diagnostic products for the animal healthcare industry. The Company's product portfolio consists of 96 diagnostic test kits and detection devices, including the Witness canine heartworm and feline leukemia diagnostic products, VetRED products and SCA 2000 products. The Witness canine heartworm and feline leukemia diagnostic products and VetRED products are licensed to the Company by their respective outside manufacturers. The Company's strategy in the animal health business is to grow from its established position in the market through new products and technologies, expanded distribution, enhanced marketing and acquisitions and licensing. The Company is combining its ability to generate products through research and development, acquisitions and licensing agreements with its ability to distribute products through established global channels. SBIO develops, manufactures and markets diagnostic products and biological products for animals. SBIO also develops and manufactures specialty products that are marketed to veterinerians. For the nine months ended 9/02, revenues fell 20% to $17.2 million. Net loss applicable to Common, from continuing operations and before acct. change totalled $3.5 million vs. an income of $1.7 million. Results reflect lower vaccine and instrument product sales and higher retention bonuses. Website: synbiotics.com Insider trading: biz.yahoo.com Synbiotics Corporation is one of the few global companies with a total focus on animal health. With offices in San Diego CA, Kansas City, MO, Rome, NY and Lyon, France, Synbiotics is dedicated to delivering innovative animal health products and services to the veterinary market. Founded in 1982, Synbiotics has evolved from a research and development company to a developer, manufacturer and marketer of veterinary diagnostics, vaccines and other animal heath related products worldwide. Several acquisitions over the past 5 years have allowed Synbiotics to widen its horizons: Beginning in 1996, with acquisitions of International Canine Genetics (ICG), Rhone Merieux Diagnostics and Prisma Systems, Synbiotics became an international player in the canine reproduction and semen freezing, stat diagnostics and serum chemistry aspects of veterinary medicine, respectively. In 1999 Synbiotics became the sole provider of the SCA2OOO, an innovative, patient-side instrument used to measure veterinary blood coagulation factors. The recent addition of the poultry diagnostic business of Kirkegaard & Perry Laboratories, Inc. (KPL), expands Synbiotics into worldwide market for poultry diagnostics and flock management. In January of 2000 Synbiotics acquired W3Commerce, LLC, a San Diego based Internet systems and service provider. With this acquisition, Synbiotics brings the expertise necessary to help provide world-class information delivery, product availability and customer service to the benefit of Synbiotics clients and animal owners worldwide.